Skip to main content
SpringerLink
Log in

Cystic Fibrosis

  • Chapter
Principles of Molecular Medicine

  • 256 Accesses

Abstract

Cystic fibrosis is a genetic disease that affects multiple organ systems, yet leads to respiratory failure and premature death in most afflicted patients. Rapid advancements in our understanding of disease pathogenesis have occurred because of the cloning of the cystic fibrosis transmembrane conductance regulator gene. Recent work has shown that volume depletion of the periciliary fluid layer and mucus dehydration reduces mucus clearance and promotes the initiation and progression of CF lung disease. Therapies that correct dysregulated salt and water transport in the lung, either by correcting or bypassing the basic cystic fibrosis trans-membrane conductance regulator defect, are now being developed and hold great promise.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 269.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 349.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Selected References

  • Andersen DH. Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathologic study. Am J Dis Child 1938;56(2): 344–399.

    Google Scholar 

  • Anderson MP, Gregory RJ, Thompson S, et al. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 1991; 253(5016):202–205.

    Article  Google Scholar 

  • App EM, King M, Helfesrieder R, Kohler D, Matthys H. Acute and long-term amiloride inhalation in cystic fibrosis lung disease: a rational approach to cystic fibrosis therapy. Am Rev Respir Dis 1990;141(3): 605–612.

    Google Scholar 

  • Aris RM, Gilligan PH, Neuringer IP, Gott KK, Rea J, Yankaskas JR. The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med 1997;155(5):1699–1704.

    Google Scholar 

  • Armstrong DS, Grimwood K, Carlin JB, et al. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997;156(4):1197–1204.

    PubMed  CAS  Google Scholar 

  • Auerbach HS, Williams M, Kirkpatrick JA, Colten HR. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet 1985;2(8457):686–688.

    Article  Google Scholar 

  • Ballard ST, Trout L, Mehta A, Inglis SK. Liquid secretion inhibitors reduce mucociliary transport in glandular airways. Am J Physiol Lung Cell Mol Physiol 2002;283(2):L329–L335.

    Google Scholar 

  • Ballmann M, Hardt HV. Hypertonic saline and recombinant human DNase: a randomised cross-over pilot study in patients with cystic fibrosis (abstract). Pediatr Pulmonol 1998;26(Suppl):A488.

    Google Scholar 

  • Bauldoff GS, Nunley DR, Manzetti JD, Dauber JH, Keenan RJ. Use of aerosolized colistin sodium in cystic fibrosis patients awaiting lung transplantation. Transplantation 1997;64(5):748–752.

    Article  Google Scholar 

  • Bear CE, Li CH, Kartner N, et al. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 1992;68(4):809–818.

    Article  Google Scholar 

  • Bennett WD, Olivier KN, Zeman KL, Hohneker KW, Boucher RC, Knowles MR. Effect of uridine 5′-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis. Am J Respir Crit Care Med 1996 153(6 Pt 1):1796-1801.

    Google Scholar 

  • Bhaskar KR, Gong DH, Bansil R, et al. Profound increase in viscosity and aggregation of pig gastric mucin at low pH. Am J Physiol 1991;261(5 Pt 1):G827–G832.

    PubMed  CAS  Google Scholar 

  • Bonfield TL, Konstan MW, Berger M. Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol 1999; 104(1):72–78.

    Article  Google Scholar 

  • Borowitz DS, Grand RJ, Durie PR. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. J Pediatr 1995;127(5):681–684.

    Article  CAS  Google Scholar 

  • Boucher RC. Human airway ion transport. Part one. Am J Respir Crit Care Med 1994;150(1):271–281.

    Google Scholar 

  • Boucher RC. Human airway ion transport. Part two. Am J Respir Crit Care Med 1994;150(2):581–593.

    Google Scholar 

  • Boucher RC. Status of gene therapy for cystic fibrosis lung disease. J Clin Invest 1999;103(4):441–445.

    Google Scholar 

  • Bowler IM, Kelman B, Worthington D, et al. Nebulised amiloride in respiratory exacerbations of cystic fibrosis: a randomised controlled trial. Arch Dis Child 1995;73(5):427–430.

    Google Scholar 

  • Bryan R, Kube D, Perez A, Davis P, Prince A. Overproduction of the CFTR R domain leads to increased levels of asialoGM1 and increased Pseudomonas aeruginosa binding by epithelial cells. Am J Respir Cell Mol Biol 1998;19(2):269–277.

    Google Scholar 

  • Caldwell RA, Grubb BR, Tarran R, Boucher RC, Knowles MR, Barker PM. In vivo airway surface liquid Cl-analysis with solid-state electrodes. J Gen Physiol 2002;119(1):3–14.

    Google Scholar 

  • Casaccia G, Trucchi A, Nahom A, et al. The impact of cystic fibrosis on neonatal intestinal obstruction: The need for prenatal/neonatal screening. Pediatr Surg Int 2003;19(1-2):75–78.

    Google Scholar 

  • Cepero R, Smith RJ, Catlin FI, Bressler KL, Furuta GT, Shandera KC. Cystic fibrosis-an otolaryngologic perspective. Otolaryngol Head Neck Surg 1987;97(4):356–360.

    Google Scholar 

  • Chillon M, Casals T, Mercier B, et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 1995;332(22): 1475–1480.

    Article  Google Scholar 

  • Clancy JP, Bebok Z, Ruiz F, et al. Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis. Am J Respir Crit Care Med 2001;163(7):1683–1692.

    Google Scholar 

  • Coakley RD, Grubb BR, Paradiso AM, et al. Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium. Proc Natl Acad Sci USA 2003;100(26):16083–16088.

    Article  CAS  Google Scholar 

  • Colombo C, Crosignani A, Melzi ML, Comi S. Hepatobiliary system. In: Yankaskas JR, Knowles MR, eds. Cystic Fibrosis in Adults. Philadelphia, PA: Lippincott-Raven, 1999; pp. 309–324.

    Google Scholar 

  • Cunningham SA, Worrell RT, Benos DJ, Frizzell RA. cAMP-stimulated ion currents in Xenopus oocytes expressing CFTR cRNA. Am J Physiol 1992;262(3 Pt 1):C783–C788.

    PubMed  CAS  Google Scholar 

  • Desmond KJ, Schwenk WF, Thomas E, Beaudry PH, Coates AL. Immediate and long-term effects of chest physiotherapy in patients with cystic fibrosis. J Pediatr 1983;103(4):538–542.

    Google Scholar 

  • di SantAgnese PA, Darling RC, Perera GA. Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas. Pediatrics 1953;12(5): 549–563.

    Google Scholar 

  • Donnelly LE, Rogers DF. Therapy for chronic obstructive pulmonary disease in the 21st century. Drugs 2003;63(19):1973–1998.

    Article  Google Scholar 

  • Durno C, Corey M, Zielenski J, Tullis E, Tsui LC, Durie P. Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology 2002;123(6):1857–1864.

    Article  Google Scholar 

  • Eigen H, Rosenstein BJ, Fitzsimmons S, Schidlow DV. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. J Pediatr 1995; 126(4):515–523.

    Google Scholar 

  • Eng P, Morton J, Douglass J, Riedler J, Wilson J, Robertson C. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatr Pulmonol 1996;21(2):77–83.

    Article  Google Scholar 

  • Farber S. Some organic digestive disturbances in early life. J Mich Med Sci 1945;44:587–594.

    Google Scholar 

  • FitzSimmons SC, Burkhart GA, Borowitz D, et al. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med 1997;336(18):1283–1289.

    Article  Google Scholar 

  • Frederiksen B, Koch C, Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997;23(5):330–335.

    Article  Google Scholar 

  • Fuchs HJ, Borowitz DS, Christiansen DH, et al. Effect of aerosolized recom-binant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med 1994;331(10):637–642 (see comments).

    Google Scholar 

  • Gaskin KJ. Intestines. In: Yankaskas JR, Knowles MR, eds. Cystic Fibrosis in Adults. Philadelphia, PA: Lippincott-Raven, 1999; pp. 325–342.

    Google Scholar 

  • Geller DE, Kaplowitz H, Light MJ, Colin AA. Allergic bronchopul-monary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Chest 1999;116(3):639–646.

    Article  Google Scholar 

  • Gilligan PH. Microbiology of cystic fibrosis lung disease. In: Yankaskas JR, Knowles MR, eds. Cystic Fibrosis in Adults. Philadelphia, PA: Lippincott-Raven Publishers, 1999; pp. 93-114.

    Google Scholar 

  • Graham A, Hasani A, Alton E, et al. No added benefit from nebulized amiloride in patients with cystic fibrosis. Eur Respir J 1993;6(9): 1243–1248.

    Google Scholar 

  • Heeckeren A, Walenga R, Konstan MW, Bonfield T, Davis PB, Ferkol T. Excessive inflammatory response of cystic fibrosis mice to bron-chopulmonary infection with Pseudomonas aeruginosa. J Clin Invest 1997;100(11):2810–2815.

    Google Scholar 

  • Illek B, Zhang L, Lewis NC, Moss RB, Dong JY, Fischer H. Defective function of the cystic fibrosis-causing missense mutation G551D is recovered by genistein. Am J Physiol 1999;277(4 Pt 1):C833–C839.

    PubMed  CAS  Google Scholar 

  • Isles A, Maclusky I, Corey M, et al. Pseudomonas cepacia infection in cystic fibrosis: An emerging problem. J Pediatr 1984;104(2):206–210.

    Google Scholar 

  • Jaffe BF, Strome M, Khaw KT, Shwachman H. Nasal polypectomy and sinus surgery for cystic fibrosis-a 10 year review. Otolaryngol Clin North Am 1977;10(1):81–90.

    Google Scholar 

  • Jayaraman S, Song YL, Vetrivel L, Shankar L, Verkman AS. Noninvasive in vivo fluorescence measurement of airway-surface liquid depth, salt concentration, and pH. J Clin Invest 2001;107(3):317–324.

    Article  Google Scholar 

  • Jebbink MC, Heijerman HG, Masclee AA, Lamers CB. Gallbladder disease in cystic fibrosis. Neth J Med 1992;41(3-4):123–126.

    Google Scholar 

  • Jensen T, Pedersen SS, Garne S, Heilmann C, Hoiby N, Koch C. Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. J Antimicrob Chemother 1987;19(6):831–838.

    Article  Google Scholar 

  • Kartner N, Hanrahan JW, Jensen TJ, et al. Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance. Cell 1991;64(4):681–691.

    Article  Google Scholar 

  • Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995;151(4):1075–1082 (see comments).

    Google Scholar 

  • Knowles M, Church N, Waltner W, et al. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N Engl J Med 1990 322(17): 1189–1194.

    Article  Google Scholar 

  • Knowles M, Gatzy J, Boucher R. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med 1981;305(25):1489–1495.

    Article  Google Scholar 

  • Knowles MR, Clarke LL, Boucher RC. Extracellular ATP and UTP induce chloride secretion in nasal epithelia of cystic fibrosis patients and normal subjects in vivo. Chest 1992;101(Suppl 3):60S–63S.

    PubMed  CAS  Google Scholar 

  • Knowles MR, Stutts MJ, Spock A, Fischer N, Gatzy JT, Boucher RC. Abnormal ion permeation through cystic fibrosis respiratory epithelium. Science 1983;221(4615):1067–1070.

    Article  PubMed  CAS  Google Scholar 

  • Knutsen A, Slavin RG. Allergic bronchopulmonary mycosis complicating cystic fibrosis. Semin Respir Infect 1992;7(3): 179–192.

    Google Scholar 

  • Koch C, Rainisio M, Madessani U, et al. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: Data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 2001;32(5):343–350.

    Article  Google Scholar 

  • Kohler D, App E, Schmitz-Schumann M, Wurtemberger G, Matthys H. Inhalation of amiloride improves the mucociliary and the cough clearance in patients with cystic fibroses. Eur J Respir Dis Suppl 1986;146: 319–326.

    PubMed  CAS  Google Scholar 

  • Konstan MW, Byard PJ, Hoppel CL, Davis PB. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 1995;332(13): 848–854 (see comments).

    Article  Google Scholar 

  • Ledson MJ, Gallagher MJ, Corkill JE, Hart CA, Walshaw MJ. Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax 1998;53(5):432–436.

    Google Scholar 

  • Matsui H, Grubb BR, Tarran R, et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 1998;95(7): 1005–1015. Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000;162(3 Part 1):891-895.

    Article  Google Scholar 

  • Muhlebach MS, Stewart PW, Leigh MW, Noah TL. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 1999;160(1):186–191.

    Google Scholar 

  • Nagel RA, Westaby D, Javaid A, et al. Liver disease and bile duct abnormalities in adults with cystic fibrosis. Lancet 1989;2(8677): 1422–1425 (see comments).

    Article  Google Scholar 

  • Nakayama K, Jia YX, Hirai H, et al. Acid stimulation reduces bactericidal activity of surface liquid in cultured human airway epithelial cells. Am J Respir Cell Mol Biol 2002;26(1):105–113.

    Google Scholar 

  • Olivier KN, Bennett WD, Hohneker KW, et al. Acute safety and effects on mucociliary clearance of aerosolized uridine 5′-triphosphate +/-amiloride in normal human adults. Am J Respir Crit Care Med 1996; 154(1):217–223.

    Google Scholar 

  • Pier GB, Grout M, Zaidi TS, et al. Role of mutant CFTR in hypersuscep-tibility of cystic fibrosis patients to lung infections. Science 1996; 271(5245):64–67.

    Article  PubMed  CAS  Google Scholar 

  • Population variation of common cystic fibrosis mutations. The Cystic Fibrosis Genetic Analysis Consortium. Hum Mutat 1994;4(3):167–177.

    Article  Google Scholar 

  • Quan JM, Tiddens HA, Sy JP, et al, for the Pulmozyme Early Intervention Trial Study Group. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities. J Pediatr 2001;139(6):813–820.

    Google Scholar 

  • Quinton PM. Chloride impermeability in cystic fibrosis. Nature 1983; 301:421–422.

    Article  PubMed  CAS  Google Scholar 

  • Ramsey BW, Pepe MS, Quan JM, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med 1999;340(1):23–30.

    Article  Google Scholar 

  • Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 1989;245(4922):1066-1073; Erratum in: Science 1989; 245(4925): 1437.

    Google Scholar 

  • Robinson M, Hemming AL, Regnis JA, et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax 1997;52(10):900–903.

    Article  Google Scholar 

  • Robinson M, Regnis JA, Bailey DL, King M, Bautovich GJ, Bye PT. Effect of hypertonic saline, amiloride, and cough on mucociliary ance in patients with cystic fibrosis. Am J Respir Crit Care Med 1996;153(5):1503–1509.

    Google Scholar 

  • Rosenstein B J, Eigen H. Risks of alternate-day prednisone in patients with cystic fibrosis. Pediatrics 1991;87(2):245–246.

    Google Scholar 

  • Rosenstein BJ, Langbaum TS. Incidence of meconium abnormalities in newborn infants with cystic fibrosis. Am J Dis Child 1980;134(1): 72–73.

    Google Scholar 

  • Rubenstein RC, Zeitlin PL. A pilot clinical trial of oral sodium 4-phenyl-butyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: Partial restoration of nasal epithelial CFTR function. Am J Respir Crit Care Med 1998;157(2):484–490.

    Google Scholar 

  • Saiman L, Marshall BC, Mayer-Hamblett N, et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2003;290(13): 1749–1756.

    Article  Google Scholar 

  • Schidlow DV, Taussig LM, Knowles MR. Cystic Fibrosis Foundation consensus conference report on pulmonary complications of cystic fibrosis. Pediatr Pulmonol 1993;15(3):187–198.

    Article  Google Scholar 

  • Schroeder TH, Reiniger N, Meluleni G, Grout M, Coleman FT, Pier GB. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract. J Immunol 2001; 166(12):7410–7418.

    PubMed  CAS  Google Scholar 

  • Scott-Jupp R, Lama M, Tanner MS. Prevalence of liver disease in cystic fibrosis. Arch Dis Child 1991;66(6):698–701.

    Article  Google Scholar 

  • Shwachman H, Kowalski M, Khaw KT. Cystic fibrosis: a new outlook. 70 patients above 25 years of age. Medicine (Baltimore) 1977;56(2): 129–149.

    Google Scholar 

  • Singer M, Martin LD, Vargaftig BB, et al. A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma. Nat Med 2004;10(2):193–196.

    Article  CAS  Google Scholar 

  • Smith JJ, Travis SM, Greenberg EP, Welsh MJ. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 1996;85(2):229–236.

    Article  Google Scholar 

  • Spector ML, Stern RC. Pneumothorax in cystic fibrosis: a 26-year experience. Ann Thorac Surg 1989;47(2):204–207.

    Article  Google Scholar 

  • Stern RC, Boat TF, Wood RE, Matthews LW, Doershuk CF. Treatment and prognosis of nasal polyps in cystic fibrosis. Am J Dis Child 1982; 136(12): 1067–1070.

    Google Scholar 

  • Stern RC, Izant RJ Jr, Boat TF, Wood RE, Matthews LW, Doershuk CF. Treatment and prognosis of rectal prolapse in cystic fibrosis. Gastroenterology 1982;82(4):707–710.

    Google Scholar 

  • Stern RC, Wood RE, Boat TF, Matthews LW, Tucker AS, Doershuk CF. Treatment and prognosis of massive hemoptysis in cystic fibrosis. Am Rev RespirDis 1978;117(5):825–828.

    Google Scholar 

  • Stevens JC, Maguiness KM, Hollingsworth J, Heilman DK, Chong SK. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy. J Pediatr Gastroenterol Nutr 1998; 26(1):80–84.

    Article  Google Scholar 

  • Stutts MJ, Canessa CM, Olsen JC, et al. CFTR as a cAMP-dependent regulator of sodium channels. Science 1995;269(5225):847–850.

    Article  Google Scholar 

  • Stutts MJ, Rossier BC, Boucher RC. Cystic fibrosis transmembrane conductance regulator inverts protein kinase A-mediated regulation of epithelial sodium channel single channel kinetics. J Biol Chem 1997; 272(22): 14,037–14,040.

    Article  Google Scholar 

  • Sun F, Tai S, Lim T, Baumann U, King M. Additive effect of dornase alfa and Nacystelyn on transportability and viscoelasticity of cystic fibrosis sputum. Can Respir J 2002;9(6):401–406.

    Google Scholar 

  • Sun L, Jiang RZ, Steinbach S, et al. The emergence of a highly transmissible lineage of cbl+Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med 1995;1(7): 661–666.

    Article  Google Scholar 

  • Suri R, Grieve R, Normand C, Metcalfe C, et al. Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis. Thorax 2002;57(10):841–846.

    Article  Google Scholar 

  • Tarran R, Grubb BR, Parsons D, et al. The CF salt controversy: in vivo observations and therapeutic approaches. Mol Cell 2001;8(1):149–158.

    Article  Google Scholar 

  • Tarran R, Loewen ME, Paradiso AM, et al. Regulation of murine airway surface liquid volume by CFTR and Ca2+-activated Cl conductances. J Gen Physiol 2002;120(3):407–418.

    Article  Google Scholar 

  • Thomas J, Cook DJ, Brooks D. Chest physical therapy management of patients with cystic fibrosis. A meta-analysis. Am J Respir Crit Care Med 1995 151(3 Pt 1):846–850.

    PubMed  CAS  Google Scholar 

  • Vasconcellos CA, Allen PG, Wohl ME, Drazen JM, Janmey PA, Stossel TP. Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin. Science 1994;263(5149):969–971.

    Article  Google Scholar 

  • Vawter GF, Shwachman H. Cystic fibrosis in adults: an autopsy study. Pathol Annu 1979;(14 Pt 2):357–382.

    Google Scholar 

  • Wilschanski M, Corey M, Durie P, et al. Diversity of reproductive tract abnormalities in men with cystic fibrosis (letter). JAMA 1996;276(8): 607–608.

    Article  Google Scholar 

  • Wilschanski M, Yahav Y, Yaacov Y, et al. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. N Engl J Med 2003;349(15):1433–1441.

    Article  Google Scholar 

  • Worlitzsch D, Tarran R, Ulrich M, et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 2002;109(3):317–325.

    Article  CAS  Google Scholar 

  • Yerxa BR, Sabater JR, Davis CW, et al. Pharmacology of INS37217 [P(1)-(uridine 5′)-P(4)-(2′-deoxycytidine 5′)tetraphosphate, tetrasodium salt ], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosis. J Pharmacol Exp Ther 2002;302(3):871–880.

    Article  CAS  Google Scholar 

  • Yoon SS, Hennigan RF, Hilliard GM, et al. Pseudomonas aeruginosa anaerobic respiration in biofilms: Relationships to cystic fibrosis pathogen-esis. Dev Cell 2002;3(4): 593–603.

    Article  Google Scholar 

  • Zabner J, Smith JJ, Karp PH, Widdicombe JH, Welsh MJ. Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro. Mol Cell 1998;2(3):397–403.

    Article  Google Scholar 

  • Zar H, Saiman L, Quittell L, Prince A. Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator. J Pediatr 1995; 126(2):230–233.

    Google Scholar 

  • Zielenski J, Tsui LC. Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet 1995;29:777–807.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cystic Fibrosis Research and Treatment Center, University of North Carolina, Chapel Hill, NC

    Scott H. Donaldson

  2. Division of Pulmonary Diseases, Department of Medicine, Cystic Fibrosis Research and Treatment Center, University of North Carolina, Chapel Hill, NC

    Richard C. Boucher

Authors
  1. Scott H. Donaldson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard C. Boucher
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine, Division of Cardiology Carolina Cardiovascular Biology Center, University of North Carolina School of Medicine, Chapel Hill, NC

    Marschall S. Runge MD, PhD  & Cam Patterson MD  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc.

About this chapter

Cite this chapter

Donaldson, S.H., Boucher, R.C. (2006). Cystic Fibrosis. In: Runge, M.S., Patterson, C. (eds) Principles of Molecular Medicine. Humana Press. https://doi.org/10.1007/978-1-59259-963-9_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-963-9_27

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-202-5

  • Online ISBN: 978-1-59259-963-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation